Evogene (EVGN) Return on Equity (2018 - 2024)
Historic Return on Equity for Evogene (EVGN) over the last 7 years, with Q4 2024 value amounting to 3.75%.
- Evogene's Return on Equity rose 54500.0% to 3.75% in Q4 2024 from the same period last year, while for Dec 2024 it was 3.75%, marking a year-over-year increase of 54500.0%. This contributed to the annual value of 0.61% for FY2024, which is 6900.0% up from last year.
- As of Q4 2024, Evogene's Return on Equity stood at 3.75%, which was up 54500.0% from 26.97% recorded in Q3 2024.
- Over the past 5 years, Evogene's Return on Equity peaked at 26.97% during Q3 2024, and registered a low of 3.45% during Q2 2024.
- Moreover, its 5-year median value for Return on Equity was 0.85% (2020), whereas its average is 0.55%.
- Over the last 5 years, Evogene's Return on Equity had its largest YoY gain of 283400bps in 2024, and its largest YoY loss of -20400bps in 2024.
- Over the past 5 years, Evogene's Return on Equity (Quarter) stood at 0.94% in 2020, then surged by 43bps to 0.53% in 2021, then tumbled by -92bps to 1.02% in 2022, then plummeted by -66bps to 1.7% in 2023, then soared by 321bps to 3.75% in 2024.
- Its Return on Equity was 3.75% in Q4 2024, compared to 26.97% in Q3 2024 and 3.45% in Q2 2024.